Albumin Based Nanoparticles for Detection of Pancreatic Cancer Cells

Author(s): Nursenem Karaca, Özlem Biçen Ünlüer*.

Journal Name: Protein & Peptide Letters

Volume 26 , Issue 4 , 2019

Submit Manuscript
Submit Proposal

Graphical Abstract:


Abstract:

Background: Molecular imaging of cancer cells using effective drug targeting systems are most interested research area in recent years. Albumin protein is a soluble and most abundant protein in circulatory system. It has a ligand-binding function and acts as a transport protein. Researchers are interested in developing albumin based nanostructured specific anti-tumor drugs in cancer therapy. Pancreatic cancer treatment or drug design for targeted pancreatic cancer cell has great importance due to it has a high mortality rate comparing other cancer types.

Objective: In this article, our goal is to develop new targeting nanoparticles based on the conjugation of albumin and Hyaluronic Acid (HA) for pancreatic cancer cells.

Method: In this article, we proposed a new technique for conjugation of albumin (BSA) and HA in nano formation. Firstly, cationic BSA is synthesized. Then, BSA-HA conjugation is obtained by interacted cationic BSA with 1000 ppm HA. Secondly, nano BSA-HA particles and nano BSA particles were synthesized according to AmiNoAcid Decorated and Light Underpinning Conjugation Approach (ANADOLUCA) method which provides a special cross-linking strategy for biomolecules using ruthenium-based amino acid monomer haptens. After characterization studies, in vitro cytotoxic activity of synthesized nano BSA-HA particles were determined for PANC-1 ATCC® CRL146 cells.

Results: According to the data, nano BSA and nano BSA-HA particles synthesized uniquely using special ruthenium-based amino acid decorated cross-linking agent, (MATyr)2-Ru-(MATyr)2.based on ANDOLUCA method. Characterization results showed that there was not any change in protein folding structures during nano formation process. In addition, nano protein particles gained fluorescence feature. When interacting synthesized nano BSA and nano BSA-HA particles with pancreatic cells, it was found that BSA nanoparticles were usually around cells and membranes, but BSA-HA nanoparticles were identified around the cells, in the cytoplasm inside the cell, and next to the cell nucleus. So, nano BSA-HA particles could be used as cancer cell imaging agent for PANC-1 ATCC® CRL146 cells.

Conclusion: The satisfactory conclusion of this study is that synthesized nano BSA-HA particles are fundamental materials for targeting pancreatic cancer cells due to HA receptors located on pancreatic cancer cells and imaging agents due to fluorescence feature of the BSA-HA nanoparticles.

Keywords: Albumin nanoparticles, hyaluronic acid, ANADOLUCA method, pancreatic cancer, cell imaging, HA receptors.

[1]
An, F.F.; Zhang, X.H. Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery. Theranostics, 2017, 7(15), 3667.
[2]
Liu, Z.; Chen, X. Simple bioconjugate chemistry serves great clinical advances: Albumin as a versatile platform for diagnosis and precision therapy. Chem. Soc. Rev., 2016, 45(5), 1432-1456.
[3]
Chakraborty, C.; Pal, S.; Doss, G.P.; Wen, Z.; Lin, C. Nanoparticles as ‘smart’ pharmaceutical delivery. Front. Biosci., 2013, 18, 1030-1050.
[4]
Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release, 2012, 157, 168-182.
[5]
Lohcharoenkal, W.; Wang, L.; Chen, Y.C.; Rojanasakul, Y. Protein nanoparticles as drug delivery carriers for cancer therapy. BioMed Res. Int., 2014, 2014, 1-12.
[6]
Hawkins, M.J.; Soon-Shiong, P.; Desai, N. Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev., 2008, 60(8), 876-885.
[7]
Fu, Q.; Sun, J.; Zhang, W.; Sui, X.; Yan, Z.; He, Z. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Patents Anticancer Drug Discov., 2009, 4(3), 262-272.
[8]
Frei, E. Albumin binding ligands and albumin conjugate uptake by cancer cells. Diabetol. Metab. Syndr., 2011, 3(1), 11.
[9]
Li, X.; Zhang, X.; Zheng, L.; Guo, W. Expression of CD44 in pancreatic cancer and its significance. Int. J. Clin. Exp. Pathol., 2015, 8(6), 6724-6731.
[10]
Cheng, X.; Kohi, S.; Koga, A.; Hirata, K.; Sato, N. Hyaluronan stimulates pancreatic cancer cell motility. Oncotarget, 2015, 7(4), 4829-4840.
[11]
Dicker, K.T.; Gurski, L.A.; Pradhan-Bhatt, S.; Witt, R.L.; Farach-Carson, M.C.; Jia, X. Hyaluronan: A simple polysaccharide with diverse biological functions. Acta Biomater., 2014, 10, 1558-1570.
[12]
Dubey, R.D.; Klippstein, R.; Wang, J.T.W.; Hodgins, N.; Mei, K.C.; Sosabowski, J.; Hider, R.C.; Abbate, V.; Gupta, P.N.; Al-Jamal, K.T. Novel hyaluronic acid conjugates for dual nuclear imaging and therapy in CD44-expressing tumors in mice in vivo. Nanotheranostics, 2017, 1(1), 59.
[13]
Chen, C.; Zhao, S. KArnad, A.; Freeman, J.W. The biology and role of CD44 in cancer progression: Therapeutic impications. J. Hematol. Oncol., 2018, 11(1), 64.
[14]
Say, R. Photosensitive aminoacid-monomer linkage and bioconjugation applications in life sciences and biotechnology. U.S. Patent 13/203,833, 2011.
[15]
Say, R.; Keçili, R.; Biçen, Ö.; Şişman, F.; Hür, D.; Denizli, A. A Novel nanoprotein particle synthesis: Nanolipase. Process Biochem., 2011, 46, 1688-1692.
[16]
Say, R.; Ünlüer, Ö.B.; Ersöz, A.; Öziç, C.; Kılıç, V. Reusable nanocopy machine particles for the replication of DNA. Biotechnol. Prog., 2015, 31, 119-123.
[17]
Say, R.; Çınar, E.; Ünlüer, Ö.B.; Ersöz, A. Resuable pectinase nano polymeric particles. J. Biocatal. Biotransform., 2014, 3, 1.
[18]
Ünlüer, Ö.B.; Ersöz, A.; Say, R.; Tomsuk, Ö.; Sivas, H. Novel nanoimaging approach: Antibodious polymeric nanolabel for intracellular alpha-fetoprotein targeted monitoring. Biotechnol. Prog., 2013, 29(1), 472-479.
[19]
Uzun, L.; Armutcu, C.; Biçen, Ö.; Ersöz, A.; Say, R.; Denizli, A. Simultaneous depletion of immunoglobulin G and albumin from human plasma using novel monolithic cryogel columns. Colloids Surf. B Biointerfaces, 2013, 112, 1-8.
[20]
Laemmli, U.K. SDS-page Laemmli method. Nature, 1970, 227, 680-685.
[21]
Keiser, K.; Johnson, C.C.; Tipton, D.A. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J. Endod., 2000, 26, 288-291.
[22]
Whatcott, C.J.; Han, H.; Posner, R.G.; Hostetter, G.; Von Hoff, D. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov., 2011, 1(4), 291-296.
[23]
Nigam, P.; Waghmode, S.; Louis, M.; Wangnoo, S.; Chavan, P.; Sarkara, D. Graphene quantum dots conjugated albumin nanoparticles for targeted drug delivery and imaging of pancreatic cancer. J. Mater. Chem., 2014, 2, 3190-3195.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 26
ISSUE: 4
Year: 2019
Page: [271 - 280]
Pages: 10
DOI: 10.2174/0929866526666190119121434
Price: $58

Article Metrics

PDF: 27
HTML: 6